Catherine Austin Fitts , president of Solari, Inc., publisher of the Solari Report, and managing member of Solari Investment Advisory Services, LLC., has created a Family Financial Disclosure Form for COVID-19 Injections — also known as the “Sane Person’s Guidebook.” Below we have reposted the form. We will include a link to the website for your convenience at the end of the post.
Introduction
The goal of this Family Financial Form is to ensure that an adverse event or death of one family member does not translate into long-lived or permanent financial destruction for the entire family.
This form was created to assist families to communicate regarding and to prepare for the family-wide financial impact of adverse events, if any, resulting from a Covid-19 injection. Examples of adverse events from Covid-19 injections include Covid-19 infection; anaphylaxis; neurological disorders; autoimmune disorders; other long-term chronic diseases; blindness and deafness; infertility, fetal damage, miscarriage, and stillbirth; and death (see Table 1 for examples of each).
Traditionally, informed consent forms for vaccination do not provide disclosure or statistics related to financial costs of possible injury, disability, or death, nor do they discuss the impact on family time, resources, health, and wealth—impacts that may include reduced career potential, divorce, and effects on siblings’ education and future plans.
Consequently, it is essential that prior to receiving a Covid-19 injection, parents and family members with financial responsibility for children and spouses not only perform thorough due diligence—providing adequate disclosures to their families regarding the potential costs to family members of adverse events or death—but also take steps to protect themselves and family members from the material adverse financial consequences of an adverse event or death.
What Are the Covid-19 Injections?
The leading Covid-19 injections currently in use in the U.S. and other OECD countries are experimental messenger RNA (mRNA) injections developed by Pfizer (with German partner BioNTech) and by biotechnology company Moderna (in partnership with the National Institute of Allergy and Infectious Diseases). The two experimental products are being distributed through emergency use authorizations (called “conditional marketing authorization” in the EU and “provisional approval” in Australia) granted following abbreviated clinical trials and without long-term safety testing. As yet, neither injection has received full approval or licensure from the FDA or any other national regulatory agency.
Though marketed as “vaccinations,” the Covid-19 mRNA injections are experimental gene therapy. Vaccine developers openly describe the never-before-authorized mRNA approach as a means of “programming a person’s cells”1 or, using Moderna’s terminology, deploying new “software.”2 In prior research, mRNA injections have displayed an intrinsic inflammatory component that has made it difficult to establish an “acceptable” risk/benefit profile.3
The mRNA approach requires an in-built “gene delivery system” (also called a “carrier system”) to deliver the synthetic mRNA into the cells’ cytoplasm before the mRNA breaks down. The Pfizer and Moderna Covid-19 injections use lipid nanoparticles (LNPs) for this purpose; the LNPs not only shield the mRNA and promote cellular uptake but also function as adjuvants, “revving up” the immune system. Pfizer’s and Moderna’s LNPs are coated with polyethylene glycol (PEG), a synthetic, nondegradable, and controversial polymer associated with adverse immune responses.
Full story here: Article Source – https://principia-scientific.com/family-financial-disclosure-form-for-covid-19-injections/